Cai; Shaopei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cai; Shaopei.The latest application filed is for "phosphatidylinositol 3-kinase inhibitors".

Company Profile

1.9.18

Cai; Shaopei - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Phosphatidylinositol 3-kinase inhibitors Grant 11,021,467 - Cai , et al. June 1, 2	2021-06-01
Phosphatidylinositol 3-kinase inhibitors Grant 10,092,563 - Cai , et al. October 9, 2	2018-10-09
Phosphatidylinositol 3-kinase Inhibitors App 20150361054 - Cai; Shaopei ; et al.	2015-12-17
Phosphatidylinositol 3-kinase Inhibitors App 20150361068 - Cai; Shaopei ; et al.	2015-12-17
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20140303182 - Cai; Shaopei ; et al.	2014-10-09
Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20130338171 - Cai; Shaopei ; et al.	2013-12-19
Bi-functional pyrazolopyridine compounds Grant 8,450,490 - Baker , et al. May 28, 2	2013-05-28
Bi-functional quinoline analogs Grant 8,394,829 - Baker , et al. March 12, 2	2013-03-12
Bi-functional pyrazolopyridine compounds Grant 8,367,829 - Baker , et al. February 5, 2	2013-02-05
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20130018058 - Cai; Shaopei ; et al.	2013-01-17
Bi-functional Pyrazolopyridine Compounds App 20130018050 - BAKER; WILLIAM R. ; et al.	2013-01-17
Bi-functional Quinoline Analogs App 20130012504 - Baker; William R. ; et al.	2013-01-10
Methods For Synthesizing Quinolinone Compounds App 20120277434 - Cai; Shaopei ; et al.	2012-11-01
Bi-functional Pyrazolopyridine Compounds App 20110275623 - BAKER; WILLIAM R. ; et al.	2011-11-10
Bi-functional Quinoline Analogs App 20110275622 - Baker; William R. ; et al.	2011-11-10
Inhibition of FGFR3 and treatment of multiple myeloma Grant 7,825,132 - Cai , et al. November 2, 2	2010-11-02
Pharmaceutically Acceptable Salts Of Quinolinone Compounds Having Improved Pharmaceutical Properties App 20090181979 - Cai; Shaopei ; et al.	2009-07-16
Inhibition of FGFR3 and treatment of multiple myeloma App 20050261307 - Cai, Shaopei ; et al.	2005-11-24
Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties App 20050209247 - Cai, Shaopei ; et al.	2005-09-22
Methods for synthesizing quinolinone compounds App 20050137399 - Cai, Shaopei ; et al.	2005-06-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.